Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Record Sales, Shrinking Profits: The Two Faces Of John B. Sanfilippo & Sons (JBSS)

On August 20, John B. Sanfilippo & Sons (NASDAQ:JBSS) reported a fiscal year that looked strong on paper and a fourth quarter that told a messier story. Full-year net sales hit $1.18 billion, a record, while fourth-quarter diluted earnings per share fell 38.3% to $0.71. Volume returned to growth for the first time in five quarters, even as margins took a hit from a supplier recall and rising input costs.

A Bar Business Ready To Scale

The full-year numbers back up the record label. Net sales climbed 6.2% to $1.18 billion, and diluted earnings per share rose 4.6% to $5.26, helped by higher selling prices and lighter inventory valuation adjustments. The company also kept its 15-year streak of shareholder payouts alive, declaring $3.50 per share in total 2026 dividends, including a 5.6% bump to the annual payout and a $1.05 special dividend, both paid September 9.

The more forward-looking story is capacity. Fourth-quarter volume grew 1.4% after five straight quarterly declines, and contract manufacturing volume jumped 12.6% on a new customer relationship. Fisher-branded snack and trail mix shipments rose 15% on expanded specialty retail and e-commerce placement. Management pointed to new high-speed bar manufacturing lines at its Elgin facility, expected to be fully operational by the second quarter of fiscal 2027, with a chewy bar line targeted for late October 2026, as the source of an estimated $300 million in incremental growth potential. New fig bar and protein bar products have already been commercialized, with more protein offerings expected by the third quarter of fiscal 2027.

Recalls And Rising Costs Bite

The quarter’s profitability tells the other side. Gross profit fell 9.5% to $44.1 million, and gross margin dropped to 15.7% from 18.1% a year earlier. A voluntary recall tied to third-party dried milk powder used in Southern Style Nuts products cost the company $2.7 million, and management also cited higher customer claims, higher snack bar ingredient costs, manufacturing inefficiencies, and higher freight expense. Input stock costs for raw nuts and dried fruit rose 12.1% on higher pecan and almond acquisition costs.

The volume picture was uneven beneath the surface. Southern Style Nuts shipments fell 27% because of the recall, Orchard Valley Harvest trail mix volume dropped 26% on category softness, and Fisher recipe nut volume fell 12% on slower grocery velocities. Commercial ingredients volume declined 5.4% on the timing of peanut crushing stock sales, and private label bar shipments slipped 3%, tracking a 5% decline across the private label bar category. CEO Jeffrey T. Sanfilippo warned that “significant external uncertainties remain, including tariffs, inflation, unpredictable commodity costs, and broader macroeconomic challenges” heading into fiscal 2027, a transition year in which he steps into the Executive Chairman role and Jasper Sanfilippo takes over as CEO in October 2026.

What The Market Is Pricing In

Hedge fund ownership of JBSS slipped from 21 funds in the prior quarter to 19 in the most recent one, a modest pullback rather than a rush for the exits. Short interest sits at 6.69% of float, enough to suggest a real bear camp has formed but not the kind of crowding that signals a squeeze setup. The stock trades at a forward P/E of 11.53 as of August 28, a multiple that does not appear to be pricing in much of the bar-expansion growth story management is pitching for fiscal 2027.

Where This Leaves Investors

The tension in this report is straightforward: a record top line and a stacked new-product pipeline sitting next to a quarter where margins got squeezed from several directions at once. For the growth story to play out, the new Elgin bar lines and protein offerings need to actually convert into the $300 million in sales management is targeting. For the skeptics, recall-driven cost spikes, declining volume in several legacy brands, and a leadership handoff arriving in the same year as major capacity additions are all reasons for caution. How fiscal 2027 volume and margins shake out will likely settle which case wins.

READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.

Disclosure: None. Follow Insider Monkey on Google News.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.